For Adults · Compounded Blend

AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin

Four metabolic peptides, one vial.

A blend of AOD-9604, MOTS-c, tesamorelin and ipamorelin, each studied in fat metabolism or the growth-hormone axis. Prescribed online after a licensed provider reviews your online visit, compounded by U.S. 503A pharmacies, and shipped discreetly to every state except Alabama, Arizona, Arkansas, California, Hawaii, Kentucky, Maryland, Massachusetts, Minnesota, Mississippi, Nebraska, North Carolina, Ohio, Oregon, South Carolina, South Dakota, Tennessee, Virginia and West Virginia.

$499

Supply

One payment for a 3-month supply.

Start your online visit →

A few private questions, then a licensed provider reviews your answers.

100% Online 503A Compounded Licensed Providers Discreet Shipping
ForbiddenRx AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin vial
At a glance
Form
Injection
Cadence
Set by your provider
Class
Four-peptide blend
Guided by
Provider review
Helps with
Metabolic category
For
Adults 18+
The basics

What is AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin?

The essentials

Four-peptide blend

FormInjection
Supply1 or 3 months
VisitOnline
  • Dosing set by your prescriber
  • Provider-reviewed, not available OTC
  • Discreet, unmarked shipping to every state except Alabama, Arizona, Arkansas, California, Hawaii, Kentucky, Maryland, Massachusetts, Minnesota, Mississippi, Nebraska, North Carolina, Ohio, Oregon, South Carolina, South Dakota, Tennessee, Virginia and West Virginia
Start your online visit →

This blend combines four peptides: AOD-9604, a modified fragment of human growth hormone (amino acids 176-191); MOTS-c, a peptide encoded by the mitochondrial genome; tesamorelin, an analog of growth-hormone-releasing hormone; and ipamorelin, a selective agonist at the ghrelin receptor.

AOD-9604 was studied in clinical trials as a weight-loss drug and did not progress to approval. MOTS-c research is mostly in animals. Tesamorelin has been studied in people for abdominal fat in HIV-associated lipodystrophy, a narrow use that does not extend to this blend. The four-way combination has not been evaluated in controlled human trials. It is a compounded preparation, not an FDA-approved medication, given as a subcutaneous injection.

This is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed. It is prescribed only where a licensed provider determines it is appropriate after reviewing your health history.

Why people ask about it

Why does AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin come up?

The blend is discussed because its components each appear in metabolic or growth-hormone research. The evidence differs a great deal between them, most of it is early, and there is no clinical evidence that combining them adds anything.

✔A provider decides, not a quiz

Every AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin prescription here follows a review by a licensed provider of your health history, current medications and goals. If it isn't appropriate for you, it isn't prescribed.

✔Compounded, not a research chemical

Your vial is compounded by a licensed U.S. 503A pharmacy and dispensed against a prescription written in your name, not sold as a "research only" product with no oversight.

Know the difference

Prescribed AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin vs. supplements and grey-market vials: what's the difference?

The short answer: unregulated supplements make claims nobody checks, "research only" vials sold online carry no prescription, no pharmacy and no accountability, and a prescribed AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin is compounded by a licensed 503A pharmacy against a provider's order written for you.

 Oral supplement"Research only" vialPrescribed AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin (Rx)
What it isAn unregulated oral productA vial sold without a prescriptionCompounded AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin dispensed on a provider's order
Licensed provider reviews youNoNoYes, before anything is dispensed
Compounded by a licensed pharmacyNoNoYes, U.S. 503A
Your name on the vialNoNoYes
Dose set by a prescriberNoNoYes

The simplest test of any peptide seller: is your name on the vial? A "research only" label means no prescriber reviewed you, no licensed pharmacy compounded it, and nobody is accountable for what is actually inside.

How it works

How does getting AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin work?

Three steps: answer a short set of medical questions, a licensed provider reviews them, and if they prescribe, a 503A pharmacy compounds and ships it.

I

Answer a few questions

A short private medical questionnaire about your history, current medications and what you are hoping to address. It takes a couple of minutes.

II

A provider reviews your answers

A provider licensed in your state reviews your answers online. No appointment, no waiting room. They decide whether AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin is appropriate.

III

Compounded & shipped

If they prescribe, a licensed U.S. 503A pharmacy compounds your vial and ships it discreetly, with your name on the label.

Who it's for

Who is AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin for?

It's for adults who want AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin prescribed and compounded properly rather than bought from a grey market. Whether it is appropriate for you is a decision for the provider who reviews your visit.

✔Interested in the metabolic category

You want these peptides prescribed and compounded properly rather than bought as "research" vials.

✔You want a real prescription

Reviewed by a licensed provider, compounded by a 503A pharmacy, dispensed with your name on the vial.

✔You prefer one vial

All four peptides are compounded together.

✔You want the dosing decided for you

The amount and schedule are set by your prescriber, not selected here or taken from a forum.

✕When it's not the right fit

This blend is not approved for weight loss, body composition or ageing, and the combination has not been studied clinically. Tesamorelin and ipamorelin act on the growth-hormone axis, which can raise blood sugar and cause fluid retention; tell your provider about diabetes or prediabetes. It should not be used by anyone with an active cancer or during pregnancy. It is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed. If you are pregnant or breastfeeding, have an active cancer diagnosis, or have significant kidney or liver disease, tell your provider in your answers. New or unexplained symptoms should be evaluated by a clinician rather than self-treated.

How to get it

How do I get AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin online?

You answer a few questions, a licensed provider reviews your answers, and if they prescribe, your medication is compounded and shipped to your door. No insurance required, no in-person appointment, no waiting room.

A few questions

Answer a short set of private medical questions. Add as many peptides as you like; one checkout, and a provider reviews each.

Online provider review

A provider licensed in your state reviews your answers online. Approval is never guaranteed.

Discreet delivery

If prescribed, your vial is compounded by a 503A pharmacy and ships in plain, unmarked packaging to every state except Alabama, Arizona, Arkansas, California, Hawaii, Kentucky, Maryland, Massachusetts, Minnesota, Mississippi, Nebraska, North Carolina, Ohio, Oregon, South Carolina, South Dakota, Tennessee, Virginia and West Virginia.

Your price is shown before you pay. No insurance needed.

Using it & safety

How is it taken, and is it safe?

AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin is compounded as injection. The amount and the schedule are set by the provider who reviews your visit. We deliberately do not publish a dosing regimen here, because that is a clinical decision about you, not a product specification.

Forms & how it's taken

Injection
Compounded as injection.
Supplied as
Strength set by your prescriber.
Dose & schedule
Set by your prescriber. Follow the directions on your label.
Supply
1-month or 3-month. Three months costs less per month.
InjectionProvider-set

Safety & side effects

⚠ Not shown to treat any condition

This blend is not approved for weight loss, body composition or ageing, and the combination has not been studied clinically. Tesamorelin and ipamorelin act on the growth-hormone axis, which can raise blood sugar and cause fluid retention; tell your provider about diabetes or prediabetes. It should not be used by anyone with an active cancer or during pregnancy. It is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed.

Reported effects are most often related to the injection itself. They can include:

  • Redness, soreness or itching at the injection site
  • Headache
  • Water retention or swelling in the limbs
  • Joint or muscle aches
  • Increases in blood glucose
  • Nausea

Tell your provider about every condition and medication before starting, including pregnancy or breastfeeding. Stop and seek care for signs of an allergic reaction: rash, swelling of the face or throat, or difficulty breathing. For emergencies call 911.

Compare your options

Which weight and metabolism peptide fits you?

A side-by-side look at the weight and metabolism options available through ForbiddenRx. Which one is appropriate for you is decided by the provider who reviews your visit.

TreatmentWhat it isFocusFormForRx required
AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin
This page
Four-peptide blendMetabolic categoryInjectionAdults 18+Yes
AOD-9604Growth-hormone fragment (hGH 176-191)Metabolic categoryInjectionAdults 18+Yes
MOTS-cMitochondrial-derived peptideMetabolic categoryInjectionAdults 18+Yes
5-Amino-1MQSmall-molecule NNMT inhibitor (oral)Metabolic categoryCapsulesAdults 18+Yes
Questions, answered

AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin FAQ

What is in this blend?

AOD-9604 (a growth-hormone fragment), MOTS-c (a mitochondrial-derived peptide), tesamorelin (a growth-hormone-releasing hormone analog) and ipamorelin (a ghrelin-receptor agonist), compounded together in one vial.

Is this a weight-loss medication?

No. It is not approved for weight loss. AOD-9604 was studied for weight loss and did not progress to approval, and the combination has not been tested in people.

Has the combination been tested in people?

No. It has not been evaluated in controlled human trials.

Is it FDA-approved?

No. It is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed.

Do I have to book an appointment?

No. You complete the questionnaire online and a licensed provider reviews it. There is no scheduling step and no waiting room.

Can I order more than one peptide?

Yes. Add each one to your cart and check out once. A provider reviews every treatment in your order.

Credibility you can verify

Care held to a higher standard

Licensed Providers

Physicians, NPs & PAs licensed in your state

503A Pharmacies

U.S.-based compounding partners

Most U.S. States

We confirm your state during intake

Explore more

Also in peptides

Start with a real prescription

If you are going to take AOD-9604 / MOTS-c / Tesamorelin / Ipamorelin, take one a licensed provider prescribed and a 503A pharmacy compounded with your name on it. Answer a few questions and a licensed provider reviews them.

Start your online visit →

  • Discreet, unmarked packaging
  • Refills so you never miss a dose
  • Labs guiding every adjustment
  • Licensed providers in every state except Alabama, Arizona, Arkansas, California, Hawaii, Kentucky, Maryland, Massachusetts, Minnesota, Mississippi, Nebraska, North Carolina, Ohio, Oregon, South Carolina, South Dakota, Tennessee, Virginia and West Virginia
Sources

Sources & references

Written by ForbiddenRx and checked against FDA prescribing information and published sources · Updated November 2026. It is general information, not a review of your own health; your provider decides what is right for you. It is provided for general educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always talk with a licensed provider about your individual health.

  1. PubMed. AOD9604 in obesity research, published studies.
  2. Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism.
  3. Falutz J et al. Effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV-infected patients with excess abdominal fat. New England Journal of Medicine.
  4. Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology.
  5. U.S. Food & Drug Administration. Human Drug Compounding Laws (Section 503A), the regulatory basis for how this preparation is dispensed.
For further reading

Clinical references

This page is educational and is not medical advice.